Wegovy vs Contrave: Label Trials and Dosing Compared
[Weight loss · Comparison]

Wegovy vs Contrave: what do the labels show?

Mechanism · Dosing · Trial results · Warnings

Short answer: Wegovy is a GLP-1 drug taken as a weekly injection or daily tablet; Contrave is a twice-daily pill combining naltrexone and bupropion.12 In separate placebo-controlled trials, Wegovy 2.4 mg averaged −14.9% at 68 weeks and Contrave −5.4% at 56 weeks. They have never been tested head to head. Wegovy has a boxed thyroid tumor warning; Contrave's covers suicidal thoughts.

How do Wegovy and Contrave compare side by side?

From the US Wegovy and Contrave labels. Trial rows come from different trials.
Wegovy (semaglutide)Contrave (naltrexone/bupropion)
How it worksGLP-1 receptor agonist1Opioid antagonist + aminoketone antidepressant2
FormWeekly injection; also a once-daily tablet1Extended-release tablet, twice daily2
Label dosingInjection: 0.25 mg weekly, stepped up every 4 weeks to 1.7 or 2.4 mg; up to 7.2 mg. Tablet: stepped up every 30 days to 25 mg daily31 tablet daily in week 1, stepping up to 2 tablets twice daily from week 42
Label trial (adults, no diabetes)Study 2 (STEP 1), 68 weeks: −14.9% vs −2.4% on placebo1COR-I, 56 weeks: −5.4% vs −1.3% on placebo2
Reached at least 5% loss83.5% vs 31.1% on placebo142% vs 17% on placebo2
Label trial (with type 2 diabetes)Study 3, 68 weeks: −9.6% vs −3.4%1COR-Diabetes, 56 weeks: −3.7% vs −1.7%2
Nausea in trials44% vs 16% on placebo132.5% vs 6.7% on placebo2
Boxed warningRisk of thyroid C-cell tumors1Suicidal thoughts and behaviors2
Other approved usesCardiovascular risk reduction; MASH with liver fibrosis; ages 12 and up (injection)1Weight management in adults only2

Reviewed . Half-life figures are shown only where the value Dose Track uses agrees with the cited source.

Can the trial numbers be compared directly?

Not fairly. Wegovy's Study 2 ran 68 weeks in 1,961 adults without diabetes.1 Contrave's COR-I ran 56 weeks, and across Contrave's four trials 45% on placebo and 46% on Contrave left before week 56, mostly in the first 12 weeks.2 The groups, lengths and ways of handling missing data differ. No trial has put the two drugs side by side.

How is each one started?

Wegovy is stepped up slowly to limit stomach side effects: the injection starts at 0.25 mg once a week and rises every 4 weeks.3 Contrave reaches its full dose in 3 weeks, and the label says to stop if you have not lost at least 5% of your weight after 12 weeks on that dose.2 Contrave should not be taken with a high-fat meal, which raises drug levels.2

More detail: Wegovy side effects, Contrave side effects, and the Wegovy and Contrave dosing schedules.

Which one is right for me?

That is a decision for you and your prescriber. Other conditions (heart disease, seizures, depression, opioid use), whether you prefer a weekly shot or daily pills, and insurance coverage often decide it. For other pill options, see Contrave vs Qsymia: how do the two weight-loss pills compare?.

Frequently asked questions

Is Wegovy stronger than Contrave?+
They have not been compared head to head. In separate label trials, Wegovy 2.4 mg averaged −14.9% at 68 weeks (placebo −2.4%) and Contrave −5.4% at 56 weeks (placebo −1.3%).12
Can you take Wegovy and Contrave together?+
Neither label reports studying the two together, so that is a question for your prescriber. The Wegovy label only rules out combining it with other semaglutide products or other GLP-1 drugs.1
Which has more nausea?+
In their own trials, nausea was reported by 44% on Wegovy 2.4 mg vs 16% on placebo, and by 32.5% on Contrave vs 6.7% on placebo.12
What are the boxed warnings?+
Wegovy: thyroid C-cell tumors seen in rodents. Contrave: suicidal thoughts and behaviors, because it contains bupropion.12
Can I track Wegovy or Contrave in Dose Track?+
Yes. Both are built in. Log weekly shots or daily tablets, follow the step-up schedule with reminders, and keep your weight next to your doses.